期刊文献+

利多卡因对hERG钾通道的影响 被引量:2

The effect of lidocaine on hERG K^+ channels
原文传递
导出
摘要 研究利多卡因对克隆h ERG钾通道的作用,探讨其对心脏电生理的影响。利用全细胞膜片钳技术和Western blot技术,观察利多卡因对稳定表达h ERG钾通道的HEK 293细胞h ERG电流和蛋白表达的影响,同时观察利多卡因对离体兔心脏心电图的影响。结果显示,利多卡因在0.3~1 000μmol·L^(-1)内呈浓度依赖性抑制h ERG电流,IC50值为88.63±7.99μmol·L^(-1);抑制作用在大于20 m V电压下更明显,不影响通道激活曲线,但具有频率依赖性特点;慢性孵育利多卡因不影响h ERG蛋白的表达;利多卡因对QTc间期没有明显影响,但浓度大于100μmol·L^(-1)可减慢心率,延长PR间期以及QRS波。结果表明,尽管利多卡因在较高浓度下具有潜在的h ERG电流抑制作用,但并不引起QTc间期延长。 We studied the effects of the lidocaine on the hERG K^+ channels with a focus on the electrophysiology of the heart. The hERG current was recorded using the conventional whole-cell patch clamp technique and the channel protein expression level was measured with Western blot in HEK 293 cells stablely expressed hERG K^+ channels. The langendorff perfusion system was used to record the ECG from isolated rabbit heart. Lidocaine inhibited bERG current in a concentration-dependent manner at 0.3-1 000 μmol·L^-1, the IC50 value was 88.63± 7.99μmol·L^-1. The inhibitory action was enhanced by positive votalge without changing the votalge-dependent activation of the channel. However, lidocaine inhibited hERG current in a frequency-dependent manner. In addition, chronic incubation of lidocaine did not change the bERG K^+ channel protein expression. ECG recordings in the isolated perfused rabbit heart demonstrated that lidocaine (〉 100 μmol·L^-1) did not affected QTc interval, but decreased the heart rate and prolonged the PR interval and QRS duration. Our results demonstrate that lidocaine potentially inhibits the hERG K^+ current at a high concentration, but does not prolonged the QTc of ECG.
出处 《药学学报》 CAS CSCD 北大核心 2016年第11期1698-1703,共6页 Acta Pharmaceutica Sinica
基金 北京市科技专项基金资助项目(Z141102004414062)
关键词 利多卡因 H ERG钾通道 心电图 矫正的QT间期 心律失常 lidocaine hERG potassium channel electrocardiogram correct QT interval cardiac arrhythmias
  • 相关文献

参考文献17

  • 1Trudeau MC, Warmke JW, Ganetzky B, et al. HERG, a human inward rectifier in the voltage-gated potassium channel family [J]. Science, 1995, 269: 92-95.
  • 2Sanguinetti MC, Jiang C, Curran ME, et al. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the lr potassium channel [J]. Cell, 1995, 81: 299-307.
  • 3Curran ME, Splawski I, Timothy KW, et al. A molecularbasis for cardiac arrhythmia: HERG mutations cause long QT syndrome [J]. Cell, 1995, 80: 795-803.
  • 4Vandenberg JI, Perry MD, Perrin MJ, et al. hERG K+ channels: structure, function, and clinical significance [J]. Physiol Rev, 2012, 92:1393 -1478.
  • 5Keating MT, Sanguinetti MC, Molecular and cellular mecha- nisms of cardiac arrhythmias [J]. Cell, 2001, 104: 569-580.
  • 6Schwartz PJ. The congenital long QT syndromes from genotype to phenotype: clinical implications [J]. J Intern Med, 2006, 259: 39-47.
  • 7Sanguinetti MC, Jurkiewicz NK. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents [J]. J Gen Physiol, 1990, 96: 195-215.
  • 8Yang T, Snyders D J, Roden DM. Inhibition of cardiac potassium currents by the vesnarinone analog OPC-18790: comparison with quinidine and dofetilide [J]. J Pharmacol Exp Ther, 1997, 280: 1170-1175.
  • 9Paul AA, Witchel H J, Hancox JC. Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine [J]. Br J Pharmacol, 2002, 136: 717-729.
  • 10Haverkamp W. Which drugs are useful during resuscitation? Which are not? [J]. Herzschrittmacherther Elektrophysiol,2016, 27: 15-19.

同被引文献11

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部